GlassScriptPhysician profile
Matthew O Nora
NPI 1134174741
$50,399.47
in general payments reported to CMS, 2019-2025
25 companies · $57.49 in 2025
The $57.49 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $11K · 2021: $5,908 · 2022: $4,214 · 2023: $5,460 · 2024: $1,499 · 2025: $57.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,816 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,900 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,815.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,900.00 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24,619.39 | 2019-2024 | |
| Boston Scientific Corporation | $13,979.71 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $7,259.12 | 2019-2024 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $1,301.88 | 2019-2024 | |
| Abbott Laboratories | $728.14 | 2019-2024 | Cardiomems |
| Janssen Pharmaceuticals, INC | $670.10 | 2020-2024 | Xarelto |
| Amgen INC. | $321.63 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.26 | 2023-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $264.57 | 2022-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.78 | 2022-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $158.29 | 2020-2023 | |
| Medtronic Vascular, INC. | $114.82 | 2019-2020 | |
| Novo Nordisk INC | $92.40 | 2022-2024 | Ozempic, Rybelsus |
| Heartflow, INC. | $49.09 | 2024 | |
| Atricure, INC. | $47.43 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $44.63 | 2023 | |
| Kestra Medical Technology Services, INC. | $41.65 | 2023 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $41.52 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $34.95 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $31.59 | 2023-2024 | Nexletol |
| Kiniksa Pharmaceuticals, LTD. | $29.23 | 2023 | Arcalyst |
| Inspire Medical Systems, INC. | $22.71 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $21.15 | 2024 | Farxiga |
| Alnylam Pharmaceuticals INC. | $20.33 | 2023 | Onpattro |
| Elutia, INC. | $15.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Nora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.